Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD
NCT00506727 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 215
Last updated 2021-06-08
Summary
Evaluate the behavioral effects of ADDERALL XR versus STRATTERA under controlled conditions utilizing the SKAMP deportment scale.
Conditions
- ADHD
Interventions
- DRUG
-
Mixed amphetamine salts (ADDERALL XR)
- DRUG
-
Atomoxetine hydrochloride
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-05
- Primary Completion
- 2004-07-02
- Completion
- 2004-07-02
Countries
- United States
Study Locations
More Related Trials
-
Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
NCT00069927 ·Status: TERMINATED ·Phase: PHASE2
-
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
NCT00356070 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of ADHD Treatment Response
NCT05650775 ·Status: COMPLETED ·Phase: PHASE1
-
ADHD Medication and Predictors of Treatment Outcome
NCT02136147 ·Status: COMPLETED
-
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
NCT00466791 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD
NCT01220440 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
NCT02780102 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
NCT03231800 ·Status: COMPLETED ·Phase: PHASE3
-
ERP Based Single-dose Predictions of Stimulants
NCT02695355 ·Status: COMPLETED ·Phase: PHASE2
-
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
NCT03292952 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00409708 ·Status: COMPLETED ·Phase: PHASE2
-
Concerta Treatment in Adults With ADHD NOS
NCT00181740 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
NCT06215144 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
NCT01624649 ·Status: COMPLETED
-
Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD
NCT02470234 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
NCT00776009 ·Status: COMPLETED ·Phase: PHASE4
-
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
NCT00000388 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
NCT00429273 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT03327402 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00428792 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
NCT02734693 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00890292 ·Status: COMPLETED ·Phase: PHASE1